Androgen receptor modulators and methods for their use
US9682933B2 · kind B2 · utility
1Cited by
1References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 29, 2015 |
| Grant date | Jun 20, 2017 |
| Priority date | — |
| Expiry date | May 29, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having a structure of Structure I:or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R4, R6, Y1 and Y2 are as defined herein, and wherein at least one of R3 or R4 is a straight-chain C1-C6 haloalkyl, are provided. Uses of such compounds for treatment of various indications, including prostate cancer, as well as methods of treatment involving such compounds are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.